The FDA granted early approval to Roche’s targeted melanoma drug, part of an emerging class of treatments that target the molecular underpinnings of cancer
From WSJ Read more »
BY ERIN DIGITALE, Stanford News
Pediatric neurologist Michelle Monje led the team that became the first to create an animal model of a rare, fatal brain tumor that strikes young children.
A pediatric brain tumor that causes gruesome suffering is finally yielding its secrets. For the first time, scientists at the Stanford University School of Medicine have cultured human cells from this cancer, Diffuse Intrinsic Pontine Glioma, and used those cells to create an animal model of the disease. Their discoveries will facilitate research on new treatments for DIPG, a tumor of school-aged children that is now almost universally fatal.
© 2008 - 2011 ESSINOVA, the Essinova design and "Essinova - The Essence of Innovation" are registered service marks of Song Essinova, LLC. "For the Well Being of Humanity" is service mark of Song Essinova, LLC.
About Us | Our Services | Privacy Policy | Terms of Use | Contact Us
